Exelixis Inc Sustainability Reports
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes small molecule medicines for difficult-to-treat cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900PJQB59O2O95R37
FIGI: BBG001SD42W4
27 reports from 2000 to 2026
